Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe M Loiseau

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
F1000Research|June 13, 2020
Inhibition of <i>in vitro</i> Ebola infection by anti-parasitic quinoline derivativesShawn Goyal, Beth Binnington, Stephen D S McCarthy, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 28, 2010
Solvent-free synthesis of pyrimidine nucleoside-aminophosphonate hybrids and their biological activity evaluationXinying Zhang, Yingying Qu, Xuesen Fan, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agentsXuesen Fan, Dong Feng, Yingying Qu, et al.
F1000Research|February 27, 2015
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionVeljko Veljkovic, Philippe M Loiseau, Bruno Figadere, et al.
Pharmaceutical Research|February 8, 2017
Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine ModelTiphany Grisin, Christian Bories, Martina Bombardi, et al.
Molecules (Basel, Switzerland)|April 27, 2024
The Synthesis of 2'-Hydroxychalcones under Ball Mill Conditions and Their Biological ActivitiesImen Abid, Wassim Moslah, Sandrine Cojean, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial ActivitiesHélène Levaique, Olivier Pamlard, Cécile Apel, et al.
Iscience|November 2, 2023
Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in <i>Leishmania infantum</i>Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2007
Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological componentsJulie Desrivot, Christine Herrenknecht, Gilles Ponchel, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
F1000Research|June 13, 2020
Inhibition of <i>in vitro</i> Ebola infection by anti-parasitic quinoline derivativesShawn Goyal, Beth Binnington, Stephen D S McCarthy, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 28, 2010
Solvent-free synthesis of pyrimidine nucleoside-aminophosphonate hybrids and their biological activity evaluationXinying Zhang, Yingying Qu, Xuesen Fan, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin BMalika Larabi, Vanessa Yardley, Philippe M Loiseau, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Practical and efficient synthesis of pyrano[3,2-c]pyridone, pyrano[4,3-b]pyran and their hybrids with nucleoside as potential antiviral and antileishmanial agentsXuesen Fan, Dong Feng, Yingying Qu, et al.
F1000Research|February 27, 2015
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionVeljko Veljkovic, Philippe M Loiseau, Bruno Figadere, et al.
Pharmaceutical Research|February 8, 2017
Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine ModelTiphany Grisin, Christian Bories, Martina Bombardi, et al.
Molecules (Basel, Switzerland)|April 27, 2024
The Synthesis of 2'-Hydroxychalcones under Ball Mill Conditions and Their Biological ActivitiesImen Abid, Wassim Moslah, Sandrine Cojean, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial ActivitiesHélène Levaique, Olivier Pamlard, Cécile Apel, et al.
Iscience|November 2, 2023
Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in <i>Leishmania infantum</i>Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2007
Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological componentsJulie Desrivot, Christine Herrenknecht, Gilles Ponchel, et al.
Pageof 12